+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 80Years
All Genders
ID05938972

Observational Study on Long-Term Effects and Predictors of Biological Treatments in Adults With Severe Chronic Rhinosinusitis With Nasal Polyps andor Severe Asthma

Led by University Hospital, Ghent · Updated on 2024-04-15

180

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a real-life, observational study involving adults with chronic rhinosinusitis with nasal polyposis CRSwNP, including those with or without asthma, who are eligible to start biological treatments. The study aims to observe long-term outcomes of biological therapies in these patients and to gain insights into how these treatments affect local and systemic immunity. Additionally, the study seeks to identify new biomarkers and predictors of treatment response. Participants will be observed while receiving biological treatments such as Mepolizumab, a monoclonal antibody, as part of their standard care. The study involves collecting nasal and blood samples, including tissue biopsies and superficial scrapings, before treatment, during, and up to 24 months of follow-up. Researchers will analyze these samples to understand the immune effects of biologicals and to discover new biomarkers. During the study, participants will be assessed for clinical characteristics, including nasal polyp scores and symptom questionnaires. The study will monitor local nasal immunity and clinical outcomes over 24 months. This includes nasal endoscopy and symptom scoring. The study is observational, so participants continue their usual care while researchers collect data and samples to evaluate treatment responses and immune changes over the long term.

CONDITIONS

Brief Title

Real Life Study of Biologicals in Patients With Severe CRSwNP

Research Team

M

Manon Blauwblomme, Masters

P

Philippe Gevaert, Prof. Dr.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here